Identifying and characterising sources of variability in digital outcome measures in Parkinson’s disease
Abstract Smartphones and wearables are widely recognised as the foundation for novel Digital Health Technologies (DHTs) for the clinical assessment of Parkinson’s disease. Yet, only limited progress has been made towards their regulatory acceptability as effective drug development tools. A key barri...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-07-01
|
Series: | npj Digital Medicine |
Online Access: | https://doi.org/10.1038/s41746-022-00643-4 |